title: [Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].
abstract: BACKGROUND
  Due to ageing of population, gerontorheumatology becomes more and more important. Both polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) typically develop in later life and they have many other common features. The aim of our study was to explore diagnostic and prognostic markers and, prospectively, establish diagnostic and therapeutic algorithm for patients with PMR and GCA.
  
  
  METHODS
  We examined 27 patients with suspected PMR or OBA. The diagnosis was verified in 22 patients. Three of them were in a long-term clinical remission. Besides examination for basic clinical and laboratory parameters, all other patients were subjected to ultrasonography of temporal artery and peripheral joints to detect any exudates. Also, they were examined for T-cell subpopulations in peripheral blood and HLA antigens.
  
  
  RESULTS
  Exudate was confirmed in 7 patients; some of them had exudate in multiple joints. Puncture of synovial fluid was done in 4 patients. Increased resistance index of temporal artery was found in 2 patients with GCA and 4 patients with PMR. GCA patients showed lower level of T-cells and increased activation of CD8-cells. Decreased count of CD8+ T-cells was observed in 56 % of PMR patients. Analysis of HLA antigens indicates that GCA, rheumatoid arthritis and, probably, PMR are associated with HLA-DR4 antigen in Slovak population.
  
  
  CONCLUSIONS
  The importance of assessment of disease activity and its prognosis in PMR or GCA patients via ultrasonographic evaluation of exudate in peripheral joints and resistance index of temporal artery as well as the analysis of T-cell distribution in peripheral blood and incidence of HLA-antigens has not been proved yet. Practical significance of monitoring the above-mentioned parameters can be verified only by further prospective study performed with a larger sample of patients.
authors.affiliation: Národný ústav reumatických chorôb, Piestany, Slovenská republika. rovensky.jozef@nurch.sk
authors.forename: J
authors.initials: J
authors.lastname: Rovenský
authors.forename: A
authors.initials: A
authors.lastname: Tuchynová
authors.forename: P
authors.initials: P
authors.lastname: Poprac
authors.forename: S
authors.initials: S
authors.lastname: Blazíková
authors.forename: V
authors.initials: V
authors.lastname: Bosák
authors.forename: V
authors.initials: V
authors.lastname: Stvrtinová
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015703:Antigens, CD / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D005260:Female; D013700:Giant Cell Arteritis / Q000175:diagnosis* / Q000276:immunology; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D011111:Polymyalgia Rheumatica / Q000175:diagnosis* / Q000276:immunology; D011379:Prognosis
chemical_list: D015703:Antigens, CD; D015415:Biomarkers; D006680:HLA Antigens